Literature DB >> 31229592

Acquisition of bedaquiline resistance by extensively drug-resistant Mycobacterium tuberculosis strain of Central Asian Outbreak clade.

I Mokrousov1, G Akhmedova2, D Polev3, V Molchanov4, A Vyazovaya4.   

Abstract

Entities:  

Year:  2019        PMID： 31229592     DOI： 10.1016/j.cmi.2019.06.014

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  5 in total

1.  Emergence of multi-drug-resistant Mycobacterium tuberculosis in Niger: A snapshot based on whole-genome sequencing.

Authors:  Zelika Harouna Hamidou; Madjid Morsli; Saidou Mamadou; Michel Drancourt; Jamal Saad
Journal:  PLoS Negl Trop Dis       Date:  2022-05-25

2.  Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.

Authors:  Maria Carla Martini; Tianbi Zhang; John T Williams; Robert B Abramovitch; Pamela J Weathers; Scarlet S Shell
Journal:  J Ethnopharmacol       Date:  2020-07-27       Impact factor: 4.360

3.  Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis.

Authors:  Nabila Ismail; Emmanuel Rivière; Jason Limberis; Stella Huo; John Z Metcalfe; Rob M Warren; Annelies Van Rie
Journal:  Lancet Microbe       Date:  2021-08-31

Review 4.  Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field.

Authors:  Navisha Dookie; Azraa Khan; Nesri Padayatchi; Kogieleum Naidoo
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

5.  Thompson loop: opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein.

Authors:  Adeniyi T Adewumi; Opeyemi S Soremekun; Mary B Ajadi; Mahmoud E S Soliman
Journal:  RSC Adv       Date:  2020-06-19       Impact factor: 4.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.